Polarization Sensitive Optical Coherence Tomography (PS-OCT) for Retinal Imaging
1 other identifier
interventional
20
1 country
1
Brief Summary
The aim of this pilot study is to assess the ability of a new polarization sensitive optical coherence tomography system to obtain high-quality images of retinal birefringence.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable healthy
Started Jun 2026
Longer than P75 for not_applicable healthy
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 27, 2015
CompletedFirst Posted
Study publicly available on registry
May 12, 2015
CompletedStudy Start
First participant enrolled
June 1, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2027
Study Completion
Last participant's last visit for all outcomes
December 1, 2028
December 9, 2025
December 1, 2025
1.5 years
April 27, 2015
December 3, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Average nerve fiber layer (NFL) birefringence
Measured birefringence values will be compared to normative values from literature
At time of imaging
Study Arms (1)
Control: Healthy
EXPERIMENTALPolarization Sensitive Optical Coherence Tomography (PS-OCT) Imaging will be used to look at the nerve fiber layer (NFL) in the healthy retina.
Interventions
OCT Imaging of the eye
Eligibility Criteria
You may qualify if:
- Male or female subjects between the ages of 18-85 years
- Healthy normal subjects with no significant eye disease, except for mild cataracts
- Subjects with clear enough cornea or clear enough media to permit imaging
- Subjects with refractive error between -5.00 sph to +5.00 sph
You may not qualify if:
- Subjects who have occludable narrow angles (without a patent peripheral iridotomy) or any other ocular or systemic pathology, which precludes safe dilation
- Subjects whose eyes have been dilated for over 6 hours will not be eligible for imaging.
- Subjects who do not or cannot understand the instructions for the PS-OCT imaging
- Subjects who are pregnant and/or breastfeeding. Date of last menstrual cycle will also be included.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Benjamin Vakoc, Ph.D.
Massachusetts General Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DEVICE FEASIBILITY
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
April 27, 2015
First Posted
May 12, 2015
Study Start (Estimated)
June 1, 2026
Primary Completion (Estimated)
December 1, 2027
Study Completion (Estimated)
December 1, 2028
Last Updated
December 9, 2025
Record last verified: 2025-12